Charles River Laboratories Announces Organizational Changes To Enhance Global Capabilities
Charles River Laboratories International, Inc. (NYSE: CRL) today
announced organizational changes which are designed to continue to
improve the Company’s operating efficiency across its global portfolio
Charles River Laboratories International, Inc. (NYSE: CRL) today announced organizational changes which are designed to continue to improve the Company’s operating efficiency across its global portfolio and enhance its ability to meet the needs of its clients. These changes represent the next step in Charles River’s continuing effort to position the Company as the partner of choice for early-stage drug development and to drive future growth. James C. Foster, Chairman, President and Chief Executive Officer, said, “In a market environment which is rapidly changing, we have continued to refine and enhance our competitive position through a combination of portfolio expansion, organizational changes, efficiency initiatives, improved data infrastructure and increasing scientific expertise. The changes we are announcing today are the logical evolution of these ongoing efforts, which we believe will ensure our clients a consistent and superior experience across our global organization. Furthermore, our intensified emphasis on efficiency will enable us to meet our clients’ expectations while maintaining and enhancing our reputation for service, responsiveness and scientific excellence.” Enhanced Efficiency Initiatives The organizational changes are designed to further enhance the Company’s worldwide productivity initiatives and promote the global management of its Research Models and Services (RMS) and Preclinical Services (PCS) businesses. The respective organizational changes are as follows: Jörg Geller, D.V.M., Ph.D., previously Corporate Executive Vice President and President, European & Asian Operations, will now directly oversee a global initiative to enhance efficiency and drive increased productivity across all of Charles River’s businesses worldwide. In his new role, Dr. Geller will assume the title of Corporate Executive Vice President, Global Productivity and Efficiency. Dr. Geller will be responsible for intensifying the Company’s focus on driving productivity, while retaining its reputation for service, responsiveness and scientific excellence. This has become increasingly important to continue to meet clients’ expectations and maintain Charles River’s strong competitive position. Dr. Geller will lead a cross-sectional team of Charles River’s functional and business-unit leaders that will be tasked with the critical initiative to drive increased productivity and efficiency at an accelerated pace.